Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,087,333
+$764,914 QoQ
Shares Held
2,574
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,100
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUYASUTA INVESTMENT ADVISORS INC holds $53,362,618 across 9 Drug Manufacturers - General names. LLY ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
102,689 | $26,079,925 | |
| 2 | MRK |
Merck & Co., Inc.
|
65,671 | $8,438,723 | |
| 3 | ABBV |
AbbVie Inc.
|
28,312 | $7,124,431 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,574 | $3,087,333 | |
| 5 | PFE |
Pfizer Inc
|
113,231 | $2,726,602 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,071 | $2,654,611 | |
| 7 | NVS |
Novartis AG
|
10,767 | $1,687,404 | |
| 8 | AMGN |
Amgen Inc
|
3,642 | $1,318,841 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,087,333 | 2,574 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,322,419 | 2,525 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,651,235 | 2,467 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,905,211 | 2,497 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,333,912 | 2,994 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,465,341 | 2,985 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,255,012 | 2,921 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,658,705 | 3,001 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,622,885 | 2,897 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,253,750 | 2,897 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,688,719 | 2,897 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,636,635 | 3,047 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,418,195 | 3,024 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $993,170 | 2,892 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,457,506 | 3,984 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $935,128 | 2,892 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $961,990 | 2,967 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $812,431 | 2,837 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $772,587 | 2,797 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $646,246 | 2,797 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $641,967 | 2,797 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $391,761 | 2,097 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $354,057 | 2,097 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $310,397 | 2,097 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $322,121 | 1,962 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $249,696 | 1,800 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||